AMERICAN INTERNATIONAL GROUP, INC. - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 70 filers reported holding RECRO PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q1 2021$32,0000.0%11,295
+0.3%
0.00%
Q4 2020$32,000
+33.3%
11,265
-2.8%
0.00%
Q3 2020$24,000
-55.6%
11,588
-2.2%
0.00%
Q2 2020$54,000
-43.2%
11,851
+2.0%
0.00%
-100.0%
Q1 2020$95,000
-57.8%
11,619
-5.5%
0.00%0.0%
Q4 2019$225,000
+66.7%
12,291
+0.5%
0.00%0.0%
Q3 2019$135,000
+8.9%
12,229
+0.4%
0.00%
Q2 2019$124,000
+82.4%
12,179
+4.5%
0.00%
Q1 2019$68,000
-17.1%
11,654
+0.4%
0.00%
Q4 2018$82,000
-1.2%
11,606
-0.8%
0.00%
Q3 2018$83,000
+45.6%
11,694
+2.9%
0.00%
Q2 2018$57,000
-40.6%
11,367
+30.5%
0.00%
Q1 2018$96,000
+12.9%
8,708
-5.1%
0.00%
Q4 2017$85,000
+3.7%
9,177
+0.5%
0.00%
Q3 2017$82,000
+39.0%
9,133
+8.1%
0.00%
Q2 2017$59,0008,4500.00%
Other shareholders
RECRO PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 850,129$2,423,0000.65%
Newtyn Management, LLC 700,000$1,995,0000.46%
Portolan Capital Management 1,293,376$3,686,0000.34%
Rubric Capital Management LP 1,076,587$3,068,0000.22%
ESSEX INVESTMENT MANAGEMENT CO LLC 99,046$282,0000.04%
Alyeska Investment Group, L.P. 736,821$2,100,0000.03%
STEPHENS INC /AR/ 510,569$1,455,0000.03%
Clear Harbor Asset Management, LLC 46,682$133,0000.02%
WYNNEFIELD CAPITAL INC 13,000$37,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 451,301$1,286,0000.01%
View complete list of RECRO PHARMA INC shareholders